Literature DB >> 29991491

ABCC6 Deficiency Promotes Development of Randall Plaque.

Emmanuel Letavernier1,2,3, Gilles Kauffenstein4, Léa Huguet5,2, Nastassia Navasiolava6, Elise Bouderlique5,2, Ellie Tang5,2, Léa Delaitre6, Dominique Bazin7, Marta de Frutos7, Clément Gay7, Joëlle Perez5,2, Marie-Christine Verpont5,2, Jean-Philippe Haymann5,2,3, Viola Pomozi8, Janna Zoll8, Olivier Le Saux8, Michel Daudon5,2,3, Georges Leftheriotis9, Ludovic Martin4,6.   

Abstract

BACKGROUND: Pseudoxanthoma elasticum (PXE) is a genetic disease caused by mutations in the ABCC6 gene that result in low pyrophosphate levels and subsequent progressive soft tissue calcifications. PXE mainly affects the skin, retina, and arteries. However, many patients with PXE experience kidney stones. We determined the prevalence of this pathology in patients with PXE and examined the possible underlying mechanisms in murine models.
METHODS: We conducted a retrospective study in a large cohort of patients with PXE and analyzed urine samples and kidneys from Abcc6-/- mice at various ages. We used Yasue staining, scanning electron microscopy, electron microscopy coupled to electron energy loss spectroscopy, and Fourier transform infrared microspectroscopy to characterize kidney calcifications.
RESULTS: Among 113 patients with PXE, 45 (40%) had a past medical history of kidney stones. Five of six computed tomography scans performed showed evidence of massive papillary calcifications (Randall plaques). Abcc6-/- mice spontaneously developed kidney interstitial apatite calcifications with aging. These calcifications appeared specifically at the tip of the papilla and formed Randall plaques similar to those observed in human kidneys. Compared with controls, Abcc6-/- mice had low urinary excretion of pyrophosphate.
CONCLUSIONS: The frequency of kidney stones and probably, Randall plaque is extremely high in patients with PXE, and Abcc6-/- mice provide a new and useful model in which to study Randall plaque formation. Our findings also suggest that pyrophosphate administration should be evaluated for the prevention of Randall plaque and kidney stones.
Copyright © 2018 by the American Society of Nephrology.

Entities:  

Keywords:  calcium; genetic renal disease; mineral metabolism

Mesh:

Substances:

Year:  2018        PMID: 29991491      PMCID: PMC6115671          DOI: 10.1681/ASN.2017101148

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  36 in total

1.  Pseudoxanthoma elasticum and nephrocalcinosis.

Authors:  Harald Seeger; Nilufar Mohebbi
Journal:  Kidney Int       Date:  2016-06       Impact factor: 10.612

2.  Calcium and vitamin D have a synergistic role in a rat model of kidney stone disease.

Authors:  Emmanuel Letavernier; Cécile Verrier; Florent Goussard; Joëlle Perez; Léa Huguet; Jean-Philippe Haymann; Laurent Baud; Dominique Bazin; Michel Daudon
Journal:  Kidney Int       Date:  2016-07-27       Impact factor: 10.612

3.  Targeted ablation of the abcc6 gene results in ectopic mineralization of connective tissues.

Authors:  John F Klement; Yasushi Matsuzaki; Qiu-Jie Jiang; Joseph Terlizzi; Hae Young Choi; Norihiro Fujimoto; Kehua Li; Leena Pulkkinen; David E Birk; John P Sundberg; Jouni Uitto
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 4.  [Epidemiology of nephrolithiasis in France].

Authors:  M Daudon
Journal:  Ann Urol (Paris)       Date:  2005-12

5.  Pyrophosphate Supplementation Prevents Chronic and Acute Calcification in ABCC6-Deficient Mice.

Authors:  Viola Pomozi; Christopher Brampton; Koen van de Wetering; Janna Zoll; Bianca Calio; Kevin Pham; Jesse B Owens; Joel Marh; Stefan Moisyadi; András Váradi; Ludovic Martin; Carolin Bauer; Jeanette Erdmann; Zouhair Aherrahrou; Olivier Le Saux
Journal:  Am J Pathol       Date:  2017-04-14       Impact factor: 4.307

6.  Pseudoxanthoma elasticum and nephrolithiasis.

Authors:  B Fabre; P Bayle; J Bazex; D Durand; L Lamant; N Chassaing
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-03       Impact factor: 6.166

7.  ABCC6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation-brief report.

Authors:  Robert S Jansen; Suzanne Duijst; Sunny Mahakena; Daniela Sommer; Flóra Szeri; András Váradi; Astrid Plomp; Arthur A Bergen; Ronald P J Oude Elferink; Piet Borst; Koen van de Wetering
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-06-26       Impact factor: 8.311

8.  ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release.

Authors:  Robert S Jansen; Aslı Küçükosmanoglu; Marcel de Haas; Sunny Sapthu; Jon Andoni Otero; Ilse E M Hegman; Arthur A B Bergen; Theo G M F Gorgels; P Borst; Koen van de Wetering
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

9.  The contribution of arterial calcification to peripheral arterial disease in pseudoxanthoma elasticum.

Authors:  Georges Leftheriotis; Gilles Kauffenstein; Jean François Hamel; Pierre Abraham; Olivier Le Saux; Serge Willoteaux; Daniel Henrion; Ludovic Martin
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

10.  Demographics and characterization of 10,282 Randall plaque-related kidney stones: a new epidemic?

Authors:  Emmanuel Letavernier; Sophie Vandermeersch; Olivier Traxer; Mohamed Tligui; Laurent Baud; Pierre Ronco; Jean-Philippe Haymann; Michel Daudon
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

View more
  14 in total

1.  Kidney Stones are Prevalent in Individuals with Pseudoxanthoma Elasticum, a Genetic Ectopic Mineralization Disorder.

Authors:  Douglas Ralph; Rina Allawh; Ian F Terry; Sharon F Terry; Jouni Uitto; Qiaoli Li
Journal:  Int J Dermatol Venereol       Date:  2020-12

2.  Stone Morphology Distinguishes Two Pathways of Idiopathic Calcium Oxalate Stone Pathogenesis.

Authors:  James C Williams; Haider Al-Awadi; Manognya Muthenini; Sharon B Bledsoe; Tarek El-Achkar; Andrew P Evan; Fredric Coe; James E Lingeman; Elaine M Worcester
Journal:  J Endourol       Date:  2022-04-29       Impact factor: 2.619

3.  Meeting report of the "Symposium on kidney stones and mineral metabolism: calcium kidney stones in 2017".

Authors:  Agnieszka Pozdzik; Naim Maalouf; Emmanuel Letavernier; Isabelle Brocheriou; Jean-Jacques Body; Benjamin Vervaet; Carl Van Haute; Johanna Noels; Romy Gadisseur; Vincent Castiglione; Frédéric Cotton; Giovanni Gambaro; Michel Daudon; Khashayar Sakhaee
Journal:  J Nephrol       Date:  2019-01-24       Impact factor: 3.902

Review 4.  Randall's plaque and calcium oxalate stone formation: role for immunity and inflammation.

Authors:  Saeed R Khan; Benjamin K Canales; Paul R Dominguez-Gutierrez
Journal:  Nat Rev Nephrol       Date:  2021-01-29       Impact factor: 28.314

Review 5.  ABCC6, Pyrophosphate and Ectopic Calcification: Therapeutic Solutions.

Authors:  Briana K Shimada; Viola Pomozi; Janna Zoll; Sheree Kuo; Ludovic Martin; Olivier Le Saux
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

6.  Relationships between Plasma Pyrophosphate, Vascular Calcification and Clinical Severity in Patients Affected by Pseudoxanthoma Elasticum.

Authors:  Georges Leftheriotis; Nastassia Navasiolava; Laetitia Clotaire; Christophe Duranton; Olivier Le Saux; Saïd Bendahhou; Audrey Laurain; Isabelle Rubera; Ludovic Martin
Journal:  J Clin Med       Date:  2022-05-05       Impact factor: 4.241

Review 7.  Precision medicine in renal stone-formers.

Authors:  Fay Hill; John A Sayer
Journal:  Urolithiasis       Date:  2018-11-20       Impact factor: 3.436

Review 8.  Pseudoxanthoma Elasticum, Kidney Stones and Pyrophosphate: From a Rare Disease to Urolithiasis and Vascular Calcifications.

Authors:  Emmanuel Letavernier; Elise Bouderlique; Jeremy Zaworski; Ludovic Martin; Michel Daudon
Journal:  Int J Mol Sci       Date:  2019-12-17       Impact factor: 5.923

9.  Essential roles of oncostatin M receptor β signaling in renal crystal formation in mice.

Authors:  Shimpei Yamashita; Tadasuke Komori; Yasuo Kohjimoto; Atsushi Miyajima; Isao Hara; Yoshihiro Morikawa
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

Review 10.  Therapeutics Development for Pseudoxanthoma Elasticum and Related Ectopic Mineralization Disorders: Update 2020.

Authors:  Hongbin Luo; Qiaoli Li; Yi Cao; Jouni Uitto
Journal:  J Clin Med       Date:  2020-12-31       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.